MedTrace Logo

Early Versus Late Administration of Insulin Glargine in T1DM During Fasting Ramadan

NCT04383990 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 185

Last updated 2021-04-28

No results posted yet for this study

Summary

To compare different timing of insulin Glargine administration (early-6 pm versus standard bedtime-10 pm) as part of standard of care in patients with type1 diabetes who wish to fast the month of Ramadan.

Conditions

  • Type1diabetes
  • Fasting
  • Insulin

Interventions

OTHER

Timing of taking insulin

To take insulin Glargine early (6-7pm) or late (bedtime-10-12pm)

Sponsors & Collaborators

  • King Abdullah International Medical Research Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-28
Primary Completion
2020-08-31
Completion
2020-11-30

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04383990 on ClinicalTrials.gov